Zentiva
Czech pharmaceutical company
Press Enter · cited answer in seconds
0 sources
Summary
Zentiva is a business[1]. Zentiva is known by 5 alternative names across languages and contexts.[2]
Key Facts
- Country: Czech Republic[3]
- Instance of: enterprise[4]
- Founder: National Property Fund[5]
- Owned by: Zentiva[6], Zentiva Group[7], Al Sirona (Luxembourg) Acquisition[8]
- Followed by: Zentiva Group[9], sanofi-aventis[10]
- Headquarters location: Prague[11]
- Commons category: Zentiva[12]
- Industry: chemical industry[13]
- Inception: 1993[14]
- Parent organization or unit: Advent International[15]
- Official website: https://www.zentiva.cz/[16]
- Employees: 651[17], 1010[18], 932[19], 811[20], 642[21], 1198[22], 1125[23], 1058[24], 1037[25]
- Official name: Zentiva, k.s.[26]
- Legal form: komanditní společnost[27]
- Total equity: 3,597,615,000[28], 3,597,618,000[29], 3,834,660,000[30], 3,597,620,000[31], 3,597,619,000[32], 3,597,617,000[33], 3,597,616,000[34]
- Total revenue: 5,214,875,000[35], 5,180,374,000[36], 15,613,216,000[37], 15,230,463,000[38], 7,438,329,000[39], 5,032,285,000[40], 23,689,628,000[41], 21,986,215,000[42], 18,109,698,000[43], 17,302,963,000[44], 4,045,000,000[45], 4,931,000,000[46]
- Net profit: 211,390,000[47], 197,781,000[48], 48,349,000[49], -502,280,000[50], 1,713,070,000[51], 1,103,361,000[52], 1,463,365,000[53], 111,642,000[54], 166,663,000[55], 715,993,000[56], 379,000,000[57]
- Total assets: 5,612,987,000[58], 5,605,273,000[59], 14,915,723,000[60], 12,850,415,000[61], 13,461,761,000[62], 5,773,575,000[63], 23,093,912,000[64], 20,001,507,000[65], 17,300,271,000[66], 15,501,219,000[67]
- Operating income: 1,028,428,000[68], 920,945,000[69], 250,910,000[70], -359,093,000[71], 1,736,819,000[72], 1,179,525,000[73], 2,171,403,000[74], 983,909,000[75]